15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Blend Labs Inc, 3 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $1.90 to $4.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $2.78 sits 86% above the current $1.50. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.01 next quarter toward $0.06 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy360%
Hold240%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Blend Labs Inc.
As of Sep, 3 of 5 firms rate BLND a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BLND EPS & revenue forecast
EPS · NEXT QUARTER
$0.01
Range $0.01 – $0.02 · 3 analysts · -48% YoY
Next period, 3 analysts expect Blend Labs Inc to earn $0.01 a share (range $0.01 – $0.02), versus $0.03 a year earlier. Full-year consensus is $0.05, growing to $0.06 the year after.
REVENUE · NEXT QUARTER
$31.0M
Range $30.0M – $32.6M · 3 analysts · -4% YoY
Revenue is expected to reach $31.0M (range $30.0M – $32.6M), -4.2% year-over-year. Full-year consensus is $128.2M, rising to $139.8M next year.
Top analysts covering Blend Labs Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BLND.
#1
Michael Turrin
Wells Fargo · Rank #352
Buy
$3.00+100.7% to target
Overall win rate
39%
+ Follow
#2
Joseph Vafi
Canaccord Genuity · Rank #406
Buy
$3.00+100.7% to target
Overall win rate
31%
+ Follow
#3
RT
Ryan Tomasello
Keefe, Bruyette & Woods
Hold
$1.90+27.1% to target
Coverage
—
+ Follow
#4
Karl Keirstead
UBS
Hold
$2.00+33.8% to target
Coverage
—
+ Follow
#5
Aaron Kimson
JMP Securities
Buy
$4.00+167.6% to target
Coverage
—
+ Follow
BLND stock forecast FAQ
What is BLND's average 12-month price target?+
The 5 analysts with a live target average $2.78 for Blend Labs Inc over the next 12 months, ranging from a $4.00 high to a $1.90 low.
Is BLND stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 3 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BLND?+
The Street-high target is $4.00 (Citizens), and the Street-low is $1.90 (Keefe, Bruyette & Woods). The average of all 5 active targets is $2.78.
How many Wall Street analysts cover BLND?+
5 analysts have an active rating on Blend Labs Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering BLND?+
Among analysts who currently cover BLND, Michael Turrin of Wells Fargo has the strongest overall Quantellect track record (Rank #352). Their current call is Buy with a $3.00 target.
What is Blend Labs Inc's projected EPS for next quarter?+
The consensus estimate is $0.01 per share (range $0.01 – $0.02) across 3 analysts. Full-year EPS is projected at $0.05, rising to $0.06 the following year.
How much revenue is Blend Labs Inc expected to report next quarter?+
Consensus revenue is $31.0M (range $30.0M – $32.6M). Full-year revenue is projected at $128.2M, growing to $139.8M next year.
Have analysts been upgrading or downgrading BLND lately?+
As of Sep, 3 of 5 firms rate BLND a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BLND calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
